Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.

NCT04491240 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Covid19
SARS-CoV-2 PNEUMONIA
COVID-19

Interventions

DRUG: EXO 1 inhalation
DRUG: EXO 2 inhalation
DRUG: Placebo inhalation

Sponsor

State-Financed Health Facility "Samara Regional Medical Center Dinasty"

Collaborators

[object Object]
[object Object]